finance.yahoo.com
Positivefinance.yahoo.com ·
Baxter International Shareholders Approve Board
NomineeKingChief Executive OfficerForests Rivers Oceans
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThis article reports standard shareholder meeting outcomes for Baxter International, a medical device company. No commercial mechanism, price impact, supply chain disruption, or margin effect is identified. The event is procedural and does not affect any product, input, or company financials.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Baxter International held its 2026 annual meeting on May 10, 2026.
- All five proposals were approved: director elections, executive compensation, auditor ratification, incentive plan amendment, and board size change.
- Each director received over 97% of votes cast; executive pay support ~91%; auditor PwC ~97%; incentive plan ~82%; board-size amendment ~90%.
- Quorum achieved with over 516 million shares represented.
- Final voting results to be disclosed in Form 8-K within four business days.